source
- BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at VenclextaBeOne Medicines has clinched an accelerated approval for its drug sonrotoclax in mantle cell lymphoma (MCL), marking the start of its bid to challenge AbbVie and Roche's Venclexta across a range of…Endpoints · 2mo ago↗ source
- STAT+: ‘No drama’ Diamantas should serve biotech well as acting FDA chiefKyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the agency.STAT · 2mo ago↗ source
- STAT+: Treatment for alcohol addiction is undergoing a seismic shift. Many say it’s overdueThe surging popularity of alternatives to Alcoholics Anonymous represents a seismic shift in the alcohol treatment landscape. Many say it's overdue.STAT · 2mo ago